Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04144777 · ClinicalTrials.gov registry record · NA
Efficacy of Solarplast for Health and Oxidative Stress
A NA study of Healthy Aging and Oxidative Stress, sponsored by Deerland Enzymes.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT04144777: Completed NA study of Healthy Aging and Oxidative Stress, sponsored by Deerland Enzymes.
NCT04144777 is a NA study of Healthy Aging and Oxidative Stress that has completed, run by Deerland Enzymes. The registered enrollment target is 84 participants, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04144777, a NA study of Healthy Aging and Oxidative Stress, has completed, sponsored by Deerland Enzymes.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
Solarplast is a unique mixture of antioxidant enzymes and single antioxidant molecules that are capable of attack oxidants that cause damage to the cells in the human body and cause premature aging. This mechanism may provide protection from stress, such as free radicals, heat, infection, as well as reduce inflammation and participate in the repair mechanism of the intestinal tract. Participants will consume Solarplast, or placebo, for 45 days with blood draws at day-0 and -45 in order to assess antioxidant capacity.
Primary Outcome
Analyze change in reactive oxygen species obtained from blood from baseline to 45 days using reactive oxygen species testing kits
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Solarplast
Study Locations (1)
Georgia
- Kennesaw State University - Kennesaw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
What the finished NCT04144777 record still lists
NCT04144777 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (29% lower).
The record links to 3 conditions, with Healthy Aging appearing as the primary indexed condition, and to 1 intervention - of which Solarplast is the first listed.
NCT04144777 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04144777 about?
NCT04144777 is a clinical study titled "Efficacy of Solarplast for Health and Oxidative Stress". Solarplast is a unique mixture of antioxidant enzymes and single antioxidant molecules that are capable of attack oxidants that cause damage to the cells in the human body and cause premature aging. This mechanism may provide protection from stress, such as free radicals, heat, infection, as well as...
What is the current status of trial NCT04144777?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-07-15. Estimated completion is 2020-05-01.
What conditions does trial NCT04144777 study?
This clinical trial studies the following conditions: Healthy Aging, Oxidative Stress, Skin Health.
What interventions are being tested in trial NCT04144777?
The interventions under investigation include: Solarplast (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04144777?
This trial is sponsored by Deerland Enzymes, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04144777 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04144777's enrollment target sits among peer trials
84 17th of 40 higher than 24 of 40 other Healthy Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
RECRUITING · NA
-
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
RECRUITING · NA
-
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
RECRUITING · NA
-
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
RECRUITING · NA
-
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
RECRUITING · NA
-
Reactive Balance Training for Fall Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI